发明名称 USE OF UROKINASE RECEPTOR ANTAGONISTS TO MODULATE ISCHEMIAREPERFUSION INJURY
摘要 The invention relates to a method of treatment and/or modulation of ischemia-reperfusion injury. In particular, the invention shows a novel, negative role for the urokinase receptor in the pathogenesis of myocardial ischemia. Consequently, the use of selective inhibitors of u-PAR are of benefit for the treatment of patients suffering from ischemic heart disease.
申请公布号 WO03051347(A1) 申请公布日期 2003.06.26
申请号 WO2002EP14478 申请日期 2002.12.18
申请人 VLAAMS INTERUNIVERSITAIR INSTITUUT VOOR BIOTECHNOLOGIE VZW;D. COLLEN RESEARCH FOUNDATION;COLLEN, DESIRE;CARMELIET, PETER;VAN AKEN, HUGO;THEILMEIER, GREGOR 发明人 COLLEN, DESIRE;CARMELIET, PETER;VAN AKEN, HUGO;THEILMEIER, GREGOR
分类号 A61K31/00;A61K31/19;A61K31/33;A61K31/343;A61K31/352;A61K31/38;A61K31/40;A61K31/405;A61K31/445;A61K31/496;A61K31/555;A61K38/02;A61K38/49;A61P9/00;(IPC1-7):A61K31/00;A61K35/80;A61K38/03;A61K38/08;A61K38/55 主分类号 A61K31/00
代理机构 代理人
主权项
地址